Shares of Edwards Lifesciences (NYSE:EW) jumped a few points as the Centers for Medicare & Medicaid affirmed coverage for the med-tech titan’s landmark Sapien transcatheter aortic valve implantation system.
EW shares jumped 2.2% to $84.78 in after hours trading as of about 6 p.m. today.